Asterand extends collaboration with Bristol-Myers

Posted on: Thu, 26 Nov 2009 05:12:00 EST


Symbols: BMY
Nov 26, 2009 (Datamonitor via COMTEX) --
BMY | Quote | Chart | News | PowerRating -- Asterand, a provider of human tissue and human tissue-based services, has extended its collaboration with Bristol-Myers Squibb Company for access to Asterand's products and services for up to three years.

The agreement will focus on access to Asterand's PhaseZERO drug discovery services and Asterand's XpressBANK of human tissue and clinical samples for the continued validation of early drug targets and support for compound optimization.

Under the extended collaboration, Asterand will continue to undertake a range of PhaseZERO studies for Bristol-Myers Squibb in the areas of compound profiling and target validation. PhaseZERO studies include gene and protein expression profiling and cell-based pharmacology assays.

Likewise, Bristol-Myers Squibb will be granted access to Asterand's XpressBANK of human tissue, bio-fluid, and cell lines and may also utilize Asterand's ProCURE custom clinical sample collection service.

Martyn Coombs, CEO of Asterand, said: "This decision by Bristol-Myers Squibb is an important validation of Asterand's products and services. Asterand provides human-based solutions that improve decision making during the development of medicines.

"Our customers incorporate human tissue-based models at all stages of development from target identification to preclinical research. We are delighted that Bristol-Myers Squibb has renewed our collaboration and our team looks forward to continuing to support their target validation and compound optimization programs."

http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon

For full details on Bristol-Myers Squibb Co (BMY) BMY. Bristol-Myers Squibb Co (BMY) has Short Term PowerRatings at TradingMarkets. Details on Bristol-Myers Squibb Co (BMY) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday February 11 04:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.